Home 9 Rachel Ceasar, PhD
Rachel Ceasar, PhD

Community Engagement and Dissemination Co-leader / Keck School of Medicine


BIO

 

Dr. Rachel Carmen Ceasar is an IAS faculty member and Interim Co-Leader for the IAS Community Engagement & Dissemination research group/committee alongside IAS Member, Dr. Ricky Bluthenthal. IAS acknowledges that addiction service delivery is a complex phenomenon that requires scientific rigor to support evidence-based activities along the entire spectrum of service from prevention to sustaining recovery. The Institute is committed to counteracting racism and health equity through concerted community engagement efforts led by this group.

Dr. Ceasar is an Assistant Professor of Clinical Population and Public Health Sciences at the Keck School of Medicine of USC. She is a medical anthropologist and also the qualitative research consultant for the Southern California Clinical and Translational Science Institute’s Biostatistics Epidemiology and Research Design. She leads the USC Maternal Cannabis Lab, where qualitative and quantitative research is conducted to document the historic and systematic inequities people face when they use cannabis during pregnancy. The goal of this work is to partner with maternal health providers, patients, and cannabis dispensaries to develop person-centered and harm reduction-based curriculum and education that supports–rather than criminalizes—parents.

 

 

PUBLICATIONS

 

  • Perceiving E-Cigarettes as Safe and Safer Alternative to Cigarettes Among Young Adults Subst Use Addctn J. 2024 Apr; 45(2):181-190. . View in PubMed
  • J Sex Med. 2024 Mar 15. . View in PubMed
  • Cannabis Use and Perinatal Health JAMA. 2024 01 16; 331(3):256-257. . View in PubMed
  • Physician Leadership and Burnout: The Need for Agency; a Qualitative Study of an Academic Institution J Healthc Leadersh. 2024; 16:121-130. . View in PubMed
  • Adolescent and Parent Perceptions of Postoperative Opioid Use: A Qualitative, Thematic Analysis J Pediatr Surg. 2023 Dec 19. . View in PubMed
  • “They might take my baby away:” Black and Latina peoples’ experiences of using cannabis during pregnancy in California while engaged in perinatal care J Perinatol. 2023 12; 43(12):1497-1499. . View in PubMed
  • Legislation has Changed But Issues Remain: Provider Perceptions of Caring for People Who Use Cannabis During Pregnancy in Safety Net Health Settings, a Qualitative Pilot Study Womens Health Rep (New Rochelle). 2023; 4(1):400-408. . View in PubMed
  • Appetite. 2022 Aug 01; 175:106075. . View in PubMed
  • Trajectories of Nicotine Use Leading to Dual and Cyclical Tobacco Product Use in Young Adults Nicotine Tob Res. 2022 06 15; 24(7):986-993. . View in PubMed
  • Associations of cannabis product source and subsequent cannabis use among adolescents Drug Alcohol Depend. 2022 04 01; 233:109374. . View in PubMed
  • Critical Challenges and Creative Solutions for Quantifying Nicotine Vaping: Qualitative Reports From Young Adults Nicotine Tob Res. 2022 02 14; 24(3):416-420. . View in PubMed
  • Factors associated with injury and blood-borne infection risk when providing assisted injection among people who inject drugs Int J Drug Policy. 2021 11; 97:103297. . View in PubMed
  • Young adult perspectives on their respiratory health symptoms since vaping Subst Abus. 2021; 42(4):428-432. . View in PubMed
  • Accessing Vaping Products When Underage: A Qualitative Study of Young Adults in Southern California Nicotine Tob Res. 2021 05 04; 23(5):836-841. . View in PubMed
  • Characterizing symptoms of e-cigarette dependence: a qualitative study of young adults BMC Public Health. 2021 05 20; 21(1):959. . View in PubMed
  • Factors associated with methamphetamine withdrawal symptoms among people who inject drugs Drug Alcohol Depend. 2021 06 01; 223:108702. . View in PubMed
  • Factors associated with health-related cannabis use intentions among a community sample of people who inject drugs in Los Angeles and San Francisco, CA 2016 to 2018 Drug Alcohol Depend. 2021 02 01; 219:108421. . View in PubMed
  • Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs Drug Alcohol Depend. 2020 06 01; 211:107932. . View in PubMed
  • Sources and Impact of Time Pressure on Opioid Management in the Safety-Net J Am Board Fam Med. 2019 May-Jun; 32(3):375-382. . View in PubMed
  • The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics Subst Abus. 2017 Apr-Jun; 38(2):213-221. . View in PubMed
  • Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use Soc Sci Med. 2017 08; 186:87-95. . View in PubMed
  • Provider Experiences With the Identification, Management, and Treatment of Co-occurring Chronic Noncancer Pain and Substance Use in the Safety Net Subst Use Misuse. 2017 01 28; 52(2):251-255. . View in PubMed
  • Primary care providers’ experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic noncancer pain patients in safety net health care settings Subst Abus. 2016; 37(1):154-60. . View in PubMed